[{"address1": "10955 Vista Sorrento Parkway", "address2": "Suite 200", "city": "San Diego", "state": "CA", "zip": "92130", "country": "United States", "phone": "858-751-4493", "website": "https://www.januxrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.", "fullTimeEmployees": 68, "auditRisk": 6, "boardRisk": 9, "compensationRisk": 9, "shareHolderRightsRisk": 8, "overallRisk": 9, "governanceEpochDate": 1717200000, "maxAge": 86400, "priceHint": 2, "previousClose": 40.3, "open": 40.55, "dayLow": 39.21, "dayHigh": 41.915, "regularMarketPreviousClose": 40.3, "regularMarketOpen": 40.55, "regularMarketDayLow": 39.21, "regularMarketDayHigh": 41.915, "beta": 3.707, "forwardPE": -24.526947, "volume": 2110881, "regularMarketVolume": 2110881, "averageVolume": 852641, "averageVolume10days": 680360, "averageDailyVolume10Day": 680360, "bid": 40.93, "ask": 41.04, "bidSize": 100, "askSize": 100, "marketCap": 2123804672, "fiftyTwoWeekLow": 5.65, "fiftyTwoWeekHigh": 65.6, "priceToSalesTrailing12Months": 291.45117, "fiftyDayAverage": 48.952, "twoHundredDayAverage": 24.028576, "currency": "USD", "enterpriseValue": 1495988992, "floatShares": 21167234, "sharesOutstanding": 51850700, "sharesShort": 2876902, "sharesShortPriorMonth": 3443028, "sharesShortPreviousMonthDate": 1713139200, "dateShortInterest": 1715731200, "sharesPercentSharesOut": 0.0555, "heldPercentInsiders": 0.09422, "heldPercentInstitutions": 0.96203005, "shortRatio": 3.31, "shortPercentOfFloat": 0.1103, "impliedSharesOutstanding": 51850700, "bookValue": 12.65, "priceToBook": 3.2379446, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1711843200, "netIncomeToCommon": -55594000, "trailingEps": -1.2, "forwardEps": -1.67, "pegRatio": -0.21, "enterpriseToRevenue": 205.296, "enterpriseToEbitda": -21.122, "52WeekChange": 2.4161801, "SandP52WeekChange": 0.26238096, "exchange": "NGM", "quoteType": "EQUITY", "symbol": "JANX", "underlyingSymbol": "JANX", "shortName": "Janux Therapeutics, Inc.", "longName": "Janux Therapeutics, Inc.", "firstTradeDateEpochUtc": 1623418200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "3a638123-d3da-3133-96c7-e6e8cabf84b3", "messageBoardId": "finmb_676965261", "gmtOffSetMilliseconds": -14400000, "currentPrice": 40.96, "targetHighPrice": 100.0, "targetLowPrice": 47.0, "targetMeanPrice": 68.57, "targetMedianPrice": 64.0, "recommendationMean": 1.7, "recommendationKey": "buy", "numberOfAnalystOpinions": 7, "totalCash": 651763008, "totalCashPerShare": 12.571, "ebitda": -70825000, "totalDebt": 24185000, "quickRatio": 61.851, "currentRatio": 62.086, "totalRevenue": 7287000, "debtToEquity": 3.688, "revenuePerShare": 0.159, "returnOnAssets": -0.08741, "returnOnEquity": -0.114980005, "freeCashflow": -33208876, "operatingCashflow": -51501000, "revenueGrowth": -0.389, "operatingMargins": -16.103039, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-06-24"}]